Overview

Polymerase Chain Reaction Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027.

Polymerase chain reaction method is widely used for diagnosing cancer, infectious diseases, in identifying target therapies as per the disease condition and personalized medicine. These are some of the factors contributing to the polymerase chain reaction market growth. This method is quite precise in obtaining results which is why technologies like qPCR and dPCR are highly preferred as they also have advantages like lesser consumption of reagents, workflow automation, real-time process monitoring, etc.
Increased incidences of infectious diseases, rising geriatric population, soaring number of hospitals and diagnostic centres and rising adoption of personalised medicine are some driving factors propelling the market growth. With the current COVID-19 pandemic, the importance of polymerase chain reaction has increased tenfold. Reverse Transcription Polymerase Chain Reaction i.e. RT-PCR has been widely used for conducting SARS COV-2 tests. Populous countries like India are unable to carry large-scale tests and this issue can be addressed by conducting pool sample testing. Sample pooling enables the test to be conducted in batches and when the pool is tested positive, the individual samples are assessed. Researchers from IIT Mumbai have developed an algorithm based on combinatorics which identifies which individual samples from a sample pool are positive. Such ventures shall boost the proliferation of the market. However, the dPCR instruments are expensive and there are some fundamental limitations in the qPCR and dPCR technologies shall impede the proliferation of the market.

Polymerase Chain Reaction Market

Market Segmentation:

By Product
•   Instruments
•   Reagents and Consumables
•   Services
•   Software
By Technology
•   Traditional PCR
•   Real-Time PCR
•   Digital PCR
By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is fragmented into product, technology and region. The product segment is categorised into instruments, reagents and consumables, services and software. The reagents and consumables segment held the largest polymerase chain reaction market share owing to their rising adoption. The technology segment is classified into traditional PCR, real time PCR and digital PCR. The real-time PCR segment is predicted to lead the market, and this can be attributed to the increase adoption of this technology for COVID-19 testing but it is the digital PCR that is expected to augment at a significant rate during the forecast period.

Regional Analysis:

The North America region is predicted to dominate the market owing to a strong presence of key market players in the region, advancements in the healthcare infrastructure, growing investments for research activities in the PCR technology.

Competitive Landscape:

Some of the prominent market players are Thermo Fisher Scientific Inc., Sygnis AG, LGC Ltd, Bio-Rad Laboratories Inc., Agilent Technologies Inc., BioMerieux S.A., RainDance Technologies Inc., Affymetrix Inc., Fluidigm Corporation, Takara Bio Inc., Beckman Coulter, Becton, Dickinson and Company, Cepheid, Clontech Laboratories, Eppendorf, GE Healthcare, Kapa Biosystems, Maxim Biotech, PerkinElmer, Promega, Siemens Healthcare.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global polymerase chain reaction market by product, by technology and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com